Whether, with reference to his reply to question 1835 on 18 July 2010, any progress has been made in reducing the number of applications before the Medicines Control Council (MCC) with regard to (a) new chemical entities (NCEs), (b) generics and (c) complementary medicines; if not, why not, in each case; if so, (i) what is the current backlog in each case and (ii) how many applications have taken longer than (aa) six months, (bb) one year, (cc) two years and (dd) three years?